NEW YORK, NY / ACCESSWIRE / June 15, 2015 / This week's events will be focused on the ongoing Greece negotiations with creditors, the largest among them being the IMF, the ECB and Germany. Additionally the FOMC minutes will be released this week pointing investors to clues as to whether the Fed is still patient regarding the proposed first rate hike. Our opinion at UltimateStockAlerts.com has been consistent on this topic for over 3 years now:
The economy continues to display immense uncertainty with deteriorating economic indicators as higher highs in major indexes are obtained with declining volume and with great caution, experiencing insignificant breakouts that usually do not accompany healthy markets. In our most recent coverage of the economy we emphasized the following to our members: "we continue to hold a negative outlook on equity markets as overvalued conditions present limited upside opportunity with significant downside risk, making long-term equity holdings a very risk bet." We stand by that sentiment and can't help but suggest that there exists significant risk for downside volatility. As a result of this market sentiment we focus on short-term undervalued opportunities that provide our members with day and swing-trade gains, providing us with concentrated upside bets while decreasing exposure associated with long-term market volatility.
To receive Free Market Forecasts along with NASDAQ/NYSE Trade Alerts CLICK HERE.
On Monday June 15, 2015 our NASDAQ/NYSE Investor Service alerted Ruthigen (NASDAQ:RTGN) to our readers. On Friday June 12, 2015 Ruthigen (NASDAQ:RTGN) and Pulmatrix announced that the previously announced merger was approved by Ruthigen’s shareholders in a special meeting. Pulmatrix had already obtained the necessary votes from its shareholders. The terms of the deal per the March 13, 2015 merger plan will result in Pulmatrix operating as a wholly owned subsidiary of Ruthigen, however the company will operate under the Pulmatrix name. Also, the CEO and President of Pulmatrix, Dr. Robert Clarke, will continue to act as CEO of the new firm. After the merger occurs, the combined company will execute a 1-for-2.5 reverse stock split. The deal is expected to consummate after market close on Monday, June 15, 2015. The new ticker for trading on Tuesday will be "PULM."
To Receive Alerts Like RTGN Before They Rally CLICK HERE.
Sunesis Pharmaceuticals (NASDAQ:SNSS) is up almost 13% in the past month after announcing positive news surrounding its Phase 3 trial of VALOR, a study of vesarozin and cytarabine in adults with relapses or refractor acute myeloid leukemia. Shares of Sunesis had their highest volume day of the year with over 10 million shares traded. After a strong early morning rally SNSS closed the day up only 2.36%.
Want Early Alerts On NYSE And NASDAQ Companies Before They Explode? Join Ultimate Stock Alerts Today!
Idera Pharmaceuticals (NASDAQ:IDRA) is another clinical stage biotech that investors should take a further look at. It develops novel therapeutics for oncology and rare diseases. The stock is up over 27.5% in the past month and could continue to rise. From a technical perspective the stock appears ready to breakout from its 200-day and 50-day moving averages. The next point of resistance seems to be $4 and if IDRA is able to breakthrough investors could witness even further upside.
Want To Get The Scoop On Other Small Cap Biotech Stocks? Join Ultimate Stock Alerts Today!
XOMA Corporation (NASDAQ:XOMA) is up a little less in the past month but could have much more upside in the coming months. Shares are up 6% in the past 30-days and there are some fairly strong catalysts that are driving this stock higher. Kingdon Capital recently increased its stake in the firm to 10.82 million shares, up from 7.57 million at the end of 1Q15. Kingdon now holds 9.2% of the shares outstanding. In late May, the company announced that it had reached a milestone to start to analyze Behcets disease drug study. Additional announcements regarding this study could cause shares to move even higher.
Get Alerts Like XOMA Before The Street Takes Notice! Join Ultimate Stock Alerts Today!
About UltimateStockAlerts.com
UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked and undervalued by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts, on your phone, compose a new text message to the number 555-888 with the message ULTIMATE. For more information visit www.UltimateStockAlerts.com.
Disclosure: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. UltimateStockAlerts.com has not been compensated nor expects to receive any compensation for distribution of our opinions and publicly available information for IDRA, XOMA, SNSS, nor RTGN as of 06/15/2015. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.
SOURCE: UltimateStockAlerts.com
